NewLimit is a biotechnology company working to radically extend human healthspan. We’re developing medicines to treat age-related diseases by reprogramming the epigenome, a new therapeutic mechanism to restore regenerative potential in aged and diseased cells. We leverage functional genomics, pooled perturbation screening, and machine learning models to unravel the biology of epigenetic aging and disease using experiments of unprecedented scale.
NewLimit is seeking an experienced scientist with a background in single cell genomics to lead our Single Cell Technology group. Single cell genomics is one of the key enabling technologies for our research program, allowing us to measure the transcriptional and epigenetic state of millions of cells to guide the design of our therapies.
As the leader of our Single Cell Technology team, you will: